AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018
Aug 30, 2018
30583_dirs_2018-08-30_4fc578f4-dff3-4d2e-82de-5aab9cbcda70.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-08-28
Reporting Person: LEWIS ALAN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-28 | Common Stock | M | 7500 | $14.39 | Acquired | 28660 | Direct |
| 2018-08-28 | Common Stock | S | 7300 | $99.110 | Disposed | 21360 | Direct |
| 2018-08-28 | Common Stock | S | 200 | $99.120 | Disposed | 21160 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-08-28 | Stock Option (Right to buy Common Stock) | $14.39 | M | 7500 | Disposed | 2019-05-11 | Common Stock (7500) | Direct |
Footnotes
F1: Reflects the number of options outstanding after the transactions from this specific stock option grant.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19